|
|
Article: BioMedEcon Reports 200% Higher Outpatient Medical Costs among Patients with Obsessive-Compulsive Disorder Compared to Matched Patients with Depression.
- Article from:
- Business Wire
- Article date:
- June 12, 2008
|
Copyright informationCOPYRIGHT 2008 Business Wire. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Results show surprisingly higher outpatient costs in OCD group despite patient matching for medical illness comorbidity
MOSS BEACH, Calif. -- BioMedEcon, a leading provider of health economics and outcomes research, presented findings from a landmark nine-year retrospective claims analysis that compared the median per-patient health care costs for patients with obsessive-compulsive disorder (OCD) versus depression. This study, supported by Jazz Pharmaceuticals, Inc., was presented at the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) annual meeting on May 3-7, in Toronto.
The purpose of this study was to demonstrate the comparative health ...